Porton Advanced

Porton Advanced is a Cell and Gene Therapy CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.

Our dedicated process and analytical development teams have established a robust platform-based USP/DSP and GMP manufacturing capability, capacity, and proprietary technologies to further empower our client’s successes.

Our services include gene and cell engineering discovery research and technology licensing, process development and analytical development, testing, drug substances (DS) and drug products (DP), and cGMP manufacturing across plasmids, cell therapy, gene therapy, virotherapy, and mRNA-based therapeutic platforms.